spot_img
2 C
London
HomeInvestors HealthAmgen sets 2025 revenue, EPS guidance ranges that include consensus

Amgen sets 2025 revenue, EPS guidance ranges that include consensus


Close up image of wooden cubes with alphabet Q4 on office desk.

mohd izzuan

  • Amgen (NASDAQ:AMGN) released 2025 revenue and guidance ranges as part of its 2024 Q4 and full-year financial results after Tuesday’s closing bell, and both include the consensus figures.
  • Revenues are projected to be $34.3B-$35.7B. Consensus is $34.53B. Non-GAAP EPS is estimated at $20.00-$21.20. Consensus is $20.82.



Source link

latest articles

explore more

LEAVE A REPLY

Please enter your comment!
Please enter your name here